A novel method of profiling the response to the PD-1 blockade therapy was studied using organotypic tumor spheroids cultured in collagen hydrogels placed in a commercially available 3D microfluidic device, the DAX-1 3D cell culture chip [79]. Here, PDCD1 is linked to neoplasm.